Prof Tamara Shushpanova,Tomsk National Research Medical Center of Russian Academy of Science, Russia
π§ Tamara Vladimirovna Shushpanova β a leading researcher at the Tomsk National Research Medical Center of the Russian Academy of Sciences, specializes in neurochemistry and neuropharmacology π§ͺ. Her research focuses on the benzodiazepine receptor system in addiction, studying ligand binding in alcohol dependence using molecular docking with GABAA receptor sites. She has authored 100+ scientific papers, holds 5 patents, and has contributed to major conferences (EPA, WPA, ECNP) π. With extensive work on innovative molecules Halodif and Halonal, her contributions drive advancements in psychiatry, pharmacology, and addiction medicine. ππ¬
Publication Profile
orcid
Education
Prof. Tamara Shushpanova is a dedicated researcher at the Laboratory of Neurobiology, Russian Academy of Sciences π§ . Her work spans Neurochemistry, Clinical Pharmacology, Psychiatry, and Addiction Medicine π₯. She has contributed significantly to understanding ethanolβs effects on the human brain and targeted therapies for correction. Notable publications include Molecular-Cellular Targets of the Pathogenetic Action of Ethanol in the Human Brain in Ontogenesis, Halonal: An Original Benzoylated Phenobarbital Derivative Anticonvulsant, and A Novel Urea Derivative Anticonvulsant π. Through her research, she advances treatments for neurological disorders, enhancing clinical applications and therapeutic strategies π¬.
Professional Memberships
Prof. Tamara Shushpanova is an active member of several prestigious professional organizations in neuroscience and psychiatry π. She is affiliated with the European Psychiatric Association (EPA), the World Psychiatric Association (WPA), and the European College of Neuropsychopharmacology (ECNP) π₯. These memberships connect her with leading experts, enabling collaboration on cutting-edge research in neurochemistry, clinical pharmacology, and addiction medicine π¬. Through these associations, she contributes to global discussions on mental health, pharmacological advancements, and innovative therapeutic strategies π§ . Her involvement ensures she remains at the forefront of scientific progress, shaping the future of psychiatry and neurobiology π.
Academic Research
Prof. Tamara Shushpanova actively shares her research on ResearchGate π, where her contributions to neurochemistry, clinical pharmacology, and psychiatry are accessible to the global scientific community π. Her profile serves as a platform for collaboration, knowledge exchange, and engagement with fellow researchers π¬. Additionally, she provides links to relevant identification and certification documents, ensuring transparency and credibility in her academic and professional endeavors π
. By maintaining an active digital presence, she enhances the visibility of her work, fostering innovation and scientific progress in the field of neuroscience and pharmacology π§
Research Focus
Tamara Shushpanova is a distinguished researcher specializing in neuropharmacology π§ π, medicinal chemistry βοΈ, and molecular neuroscience π¬. Her work primarily focuses on the development of novel anticonvulsants, particularly targeting GABAA receptors for conditions like epilepsy and alcohol withdrawal syndrome. She explores drug delivery systems π, enantiomeric drug behavior π, and neuroimmune interactions π§¬. Her research spans molecular docking, chemometric analysis, and in vivo pharmacological studies, contributing to innovative treatments for neurological disorders. Additionally, she investigates prenatal alcohol exposure π·πΌ and its impact on brain development, emphasizing glioblasts and neuronal receptor formation in neuroimmune regulation.
Publication Top Notes